Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With an Optimized Background Regimen (OBR) in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug Resistance

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
The primary objective of this study is to evaluate the antiviral activity of lenacapavir (formerly GS-6207) administered as an add-on to a failing regimen (functional monotherapy) in people living with HIV (PLWH) with multi-drug resistance (MDR).
Epistemonikos ID: 859c88bd64507d0810c78f7daa6422c0e5e5796c
First added on: May 06, 2024